Cardioprotective and survival benefits of long-term combined therapy with beta2 adrenoreceptor (AR) agonist and betal AR blocker in dilated cardiomyopathy postmyocardial infarction

查看全文 作　　者：Ahmet I;Krawczyk M;Zhu W; 出　　处：《J Pharmacol Exp Ther》索引2008年第325卷第2期,共0页